{
  "zip": "6473921",
  "sector": "",
  "fullTimeEmployees": 155,
  "longBusinessSummary": "RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, with a planned Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), a SK2 selective inhibitor targeting various indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and in Phase 2 studies for irritable bowel syndrome with diarrhea; RHB-107, a Phase 2-stage serine protease inhibitor for cancer and inflammatory gastrointestinal diseases, and is also being evaluated for COVID-19; and RHB-106, an encapsulated bowel preparation. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.",
  "city": "Tel Aviv",
  "phone": "972 3 541 3131",
  "country": "Israel",
  "companyOfficers": [],
  "website": "http://www.redhillbio.com",
  "maxAge": 1,
  "address1": "21 Haâarbaâa Street",
  "fax": "972 3 541 3144",
  "industry": "",
  "previousClose": 0.67,
  "regularMarketOpen": 0.67,
  "twoHundredDayAverage": 0.67,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.67,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.67,
  "fiftyDayAverage": 0.67,
  "trailingAnnualDividendRate": null,
  "open": 0.67,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.711659,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.67,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 10000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 164631072,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 158,
  "priceToSalesTrailing12Months": 3.7005725,
  "dayLow": 0.67,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 10000,
  "fiftyTwoWeekHigh": 0.67,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.67,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.67,
  "exchange": "PNK",
  "shortName": "REDHILL BIOPHARMA LTD",
  "longName": "RedHill Biopharma Ltd.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "REDIF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_104926324",
  "uuid": "cc5256b6-49f8-3f8b-bfca-82da5e164f39",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 1.71,
  "beta3Year": null,
  "profitMargins": -1.4280901,
  "enterpriseToEbitda": -1.516,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 234960000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.771,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.00196,
  "netIncomeToCommon": -63533000,
  "trailingEps": -1.796,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 0.86900127,
  "heldPercentInsiders": 0.04942,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 22881833,
  "enterpriseValue": 76082832,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.67,
  "logo_url": "https://logo.clearbit.com/redhillbio.com"
}